Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity A Pelin, S Boulton, LA Tamming, JC Bell, R Singaravelu Expert opinion on biological therapy 20 (9), 1083-1097, 2020 | 19 | 2020 |
DNA based vaccine expressing SARS-CoV-2 Spike-CD40L fusion protein confers protection against challenge in a Syrian hamster model LA Tamming, D Duque, A Tran, W Zhang, A Pfeifle, E Laryea, J Wu, ... Frontiers in Immunology 12, 785349, 2022 | 13 | 2022 |
DNA lipid nanoparticle vaccine targeting outer surface protein C affords protection against homologous Borrelia burgdorferi needle challenge in mice A Pfeifle, SN Thulasi Raman, C Lansdell, W Zhang, L Tamming, ... Frontiers in Immunology 14, 1020134, 2023 | 12 | 2023 |
Cellular and humoral immunogenicity of a candidate DNA vaccine expressing SARS-CoV-2 spike subunit 1 KA Alluhaybi, RH Alharbi, RY Alhabbab, ND Aljehani, SS Alamri, ... Vaccines 9 (8), 852, 2021 | 12 | 2021 |
Single immunization with recombinant ACAM2000 vaccinia viruses expressing the spike and the nucleocapsid proteins protects hamsters against SARS-CoV-2-caused clinical disease Y Deschambault, J Lynch, B Warner, K Tierney, D Huynh, R Vendramelli, ... Journal of Virology 96 (9), e00389-22, 2022 | 7 | 2022 |
The expression kinetics and immunogenicity of lipid nanoparticles delivering plasmid DNA and mRNA in mice W Zhang, A Pfeifle, C Lansdell, G Frahm, J Cecillon, L Tamming, C Gravel, ... Vaccines 11 (10), 1580, 2023 | 6 | 2023 |
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX JT Whelan, R Singaravelu, F Wang, A Pelin, LA Tamming, G Pugliese, ... Frontiers in Immunology 13, 1050250, 2023 | 4 | 2023 |
Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages C Gravel, A Muralidharan, A Duran, A Zetner, A Pfeifle, W Zhang, ... Iscience 24 (11), 2021 | 4 | 2021 |
Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses SNT Raman, A Zetner, AM Hashem, D Patel, J Wu, C Gravel, J Gao, ... Emerging Microbes & Infections 12 (1), 2192821, 2023 | 2 | 2023 |
Lipid nanoparticle encapsulation improves effectiveness of a Delta Spike-CD40L DNA vaccine against homologous and heterologous SARS-CoV-2 challenge in Syrian hamsters L Tamming, D Duque, A Tran, C Lansdell, G Frahm, J Wu, EEF Fekete, ... Molecular Therapy Methods & Clinical Development, 2024 | | 2024 |
A Modified Recombinant DNA‐Based SARS‐CoV‐2 Vaccine Expressing Stabilized Uncleavable Spike Protein Elicits Humoral and Cellular Immunity against Various SARS‐CoV‐2 Variants of … RH Abdulal, MY Khan, ND Aljehani, ZI Fallata, RH AlHarbi, ... Transboundary and Emerging Diseases 2023 (1), 5279979, 2023 | | 2023 |